HOME › DRUGS › SALMETEROL XINAFOATE;FLUTICASONE PROPIONATE
ACTIVE SUBSTANCE / INN

SALMETEROL XINAFOATE;FLUTICASONE PROPIONATE

Brand name(s): Airexar Spiromax
EMA LISTED
WITHDRAWN
Pulmonary Disease, Chronic Obstructive;Asthma
ACTIVE SUBSTANCE
Salmeterol Xinafoate;Fluticasone Propionate
REGULATORS
EMA
SPONSORS / MAH
Teva B.V.
TOTAL APPLICATIONS
1
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
Airexar SpiromaxTeva B.V.Withdrawn18/08/2016Pulmonary Disease, Chronic Obstructive;Asthma

FULL INTELLIGENCE ON SALMETEROL XINAFOATE;FLUTICASONE PROPIONATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →